MEI Pharma, Inc. (MEIP)
NASDAQ: MEIP · Real-Time Price · USD
4.530
-0.320 (-6.60%)
At close: Sep 3, 2025, 4:00 PM
4.600
+0.070 (1.55%)
Pre-market: Sep 4, 2025, 8:00 AM EDT
MEI Pharma Stock Forecast
Stock Price Forecast
There is currently no analyst price target forecast available for MEI Pharma.
Price Target: $ (0.00%)
Analyst Consensus: n/a
Analyst Ratings
There are currently no analyst ratings available for MEI Pharma.
Recommendation Trends
| Rating | Feb '24 | Mar '24 | Apr '24 | May '24 | Jun '24 | Jul '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 0 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 1 | 1 | 1 | 1 | 1 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 2 | 2 | 2 | 0 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Laidlaw & Co. | Laidlaw & Co. | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Jul 23, 2024 |
| Stifel | Stifel | Hold Maintains $7 | Hold | Maintains | $7 | +54.53% | Apr 12, 2024 |
| Stifel | Stifel | Hold Maintains $8 → $7 | Hold | Maintains | $8 → $7 | +54.53% | Feb 14, 2024 |
| Stifel | Stifel | Hold Maintains $10 → $9 | Hold | Maintains | $10 → $9 | +98.68% | Sep 27, 2023 |
| Brookline Capital | Brookline Capital | Strong Buy Maintains $80 | Strong Buy | Maintains | $80 | +1,666.00% | May 23, 2023 |
Financial Forecast
Revenue This Year
n/a
from 65.30M
Revenue Next Year
25.50M
EPS This Year
-6.41
from 2.67
EPS Next Year
-3.78
from -6.41
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | n/a | 26.3M | |
| Avg | n/a | 25.5M | |
| Low | n/a | 24.5M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
EPS Forecast
| EPS | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | -6.59 | -3.90 | |
| Avg | -6.41 | -3.78 | |
| Low | -6.15 | -3.64 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.